Home / Inspections / 1201208

FDA Inspection 1201208 — AdventHealth Cancer Institute Cellular Therapy Laboratory

AdventHealth Cancer Institute Cellular Therapy Laboratory — FEI 3003926638

The FDA completed an inspection of AdventHealth Cancer Institute Cellular Therapy Laboratory on March 23, 2023 in Orlando, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 23, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Orlando, FL (United States)

Facility

Other inspections at this facility

  • 995148 (NAI Thu Nov 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 892893 (NAI Thu Aug 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources